Author: Dwyer, Connor J.; Cloud, Colleen A.; Wang, Cindy; Heidt, Philip; Chakraborty, Paramita; Duke, Tara F.; McGue, Shannon; Jeffcoat, Braxton; Dunne, Jaclyn; Johnson, Logan; Choi, Seungho; Nahhas, Georges J.; Gandy, Amy S.; Babic, Nikolina; Nolte, Frederick S.; Howe, Philip; Ogretmen, Besim; Gangaraju, Vamsi K.; Tomlinson, Stephen; Madden, Brian; Bridges, Tracy; Flume, Patrick A.; Wrangle, John; Rubinstein, Mark P.; Baliga, Prabhakar K.; Nadig, Satish N.; Mehrotra, Shikhar
Title: Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients Cord-id: 6qibo9rc Document date: 2021_5_1
ID: 6qibo9rc
Snippet: The SARS-CoV-2 viral pandemic has induced a global health crisis, which requires more in-depth investigation into immunological responses to develop effective treatments and vaccines. To understand protective immunity against COVID-19, we screened over 60,000 asymptomatic individuals in the Southeastern United States for IgG antibody positivity against the viral spike protein, and approximately three percent were positive. Of these three percent, individuals with the highest anti-S or anti-RBD I
Document: The SARS-CoV-2 viral pandemic has induced a global health crisis, which requires more in-depth investigation into immunological responses to develop effective treatments and vaccines. To understand protective immunity against COVID-19, we screened over 60,000 asymptomatic individuals in the Southeastern United States for IgG antibody positivity against the viral spike protein, and approximately three percent were positive. Of these three percent, individuals with the highest anti-S or anti-RBD IgG level showed a strong correlation with inhibition of ACE2 binding and cross-reactivity against non-SARS-CoV-2 coronavirus S-proteins. We also analyzed samples from 94 SARS-CoV-2 patients and compared them to asymptomatic individuals. SARS-CoV-2 symptomatic patients had decreased antibody responses, ACE2 binding inhibition, and antibody cross-reactivity. Our study shows that healthy individuals can mount robust immune responses against SARS-CoV-2 without symptoms. Further, IgG antibody responses against S and RBD may correlate with high inhibition of ACE2 binding in individuals tested for SARS-CoV-2 infection or vaccination.
Search related documents:
Co phrase search for related documents- acute respiratory syndrome and longitudinal immune response: 1, 2, 3
- acute respiratory syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and longitudinal study assess: 1, 2, 3, 4, 5
- acute respiratory syndrome and low antibody response: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome and low asymptomatic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44
- acute respiratory syndrome and low medium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
- acute respiratory syndrome and low medium value: 1, 2, 3
- adaptive immunity and longitudinal immune response: 1, 2
- adaptive immunity and longitudinal immune response follow: 1, 2
- adaptive immunity and longitudinal study: 1
- adaptive immunity and low asymptomatic: 1, 2
- longitudinal study and low asymptomatic: 1, 2, 3
- longitudinal study and low medium: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date